← All Investors
ALNYLAM PHARMACEUTICALS INC
ALNY 1 09-15-27
Holders
0
Combined Value
$0
Combined Shares
0
Investor Activity
BUYSELLImplied priceClick a quarter to see who traded
Held By
| Investor | Value | % of Portfolio | Avg Buy Price | Gain | Last Activity | As of |
|---|
No tracked investors currently hold this security.
Recent Activity
| Quarter | Investor | Action | Est. Value | Est. Price |
|---|---|---|---|---|
| Q3 2025 | Israel Englander - Millennium Management | SOLD OUT | −$26M | ~$1.30 |
| Q3 2025 | Ken Griffin - Citadel Advisors | SOLD OUT | −$6.5M | ~$1.30 |
| Q3 2025 | Howard Marks - Oaktree Capital | SOLD OUT | −$976K | ~$1.30 |
| Q2 2025 | Israel Englander - Millennium Management | NEW BUY | +$26M | ~$1.30 |
| Q2 2025 | Steve Cohen - Point72 | SOLD OUT | −$5.8M | ~$1.15 |
| Q2 2025 | Ken Griffin - Citadel Advisors | SELL | −$3.9M | ~$1.30 |
| Q2 2025 | Howard Marks - Oaktree Capital | SELL | −$325K | ~$1.30 |
| Q1 2025 | Ken Griffin - Citadel Advisors | NEW BUY | +$9.2M | ~$1.15 |
| Q1 2025 | Steve Cohen - Point72 | NEW BUY | +$5.8M | ~$1.15 |
| Q1 2025 | Howard Marks - Oaktree Capital | SELL | −$403K | ~$1.15 |
| Q4 2024 | Israel Englander - Millennium Management | SOLD OUT | −$23M | ~$1.17 |
| Q4 2024 | Howard Marks - Oaktree Capital | SELL | −$479K | ~$1.07 |
| Q3 2024 | Ken Griffin - Citadel Advisors | SOLD OUT | −$29M | ~$1.08 |
| Q3 2024 | Israel Englander - Millennium Management | NEW BUY | +$23M | ~$1.17 |
| Q3 2024 | Howard Marks - Oaktree Capital | NEW BUY | +$2.1M | ~$1.17 |
| Q2 2024 | Ken Griffin - Citadel Advisors | NEW BUY | +$29M | ~$1.08 |
Ownership History
| Period | Holders | Total Shares | Δ Shares | Total Value | Implied Price |
|---|---|---|---|---|---|
| Q2 2025 | 3 | 25,750,000 | +83.9% | $33M | $1.30 |
| Q1 2025 | 3 | 14,000,000 | +937.0% | $16M | $1.15 |
| Q4 2024 | 1 | 1,350,000 | −93.8% | $1.4M | $1.07 |
| Q3 2024 | 2 | 21,800,000 | −21.3% | $25M | $1.17 |
| Q2 2024 | 1 | 27,710,000 | — | $29M | $1.08 |